effectiveness < effects < efferents

Facettes :

List of bibliographic references indexed by effects

Number of relevant bibliographic references: 290.
[0-20] [0 - 20][0 - 50][20-40]

Ident.	Authors (with country if any)	Title
000010 (2017)	Mahshad Kolahdouzan [Canada] ; Mazen J. Hamadeh [Canada]	The neuroprotective effects of caffeine in neurodegenerative diseases.
000025 (2017)	Soha Alomar [Arabie saoudite] ; Nicolas K K. King [Canada] ; Joseph Tam [Canada] ; Ausaf A. Bari [États-Unis] ; Clement Hamani [Canada] ; Andres M. Lozano [Canada]	Speech and language adverse effects after thalamotomy and deep brain stimulation in patients with movement disorders: A meta-analysis.
000094 (2017)	Nadhir Litim [Canada] ; Marc Morissette [Canada] ; Thérèse Di Paolo [Canada]	Effects of progesterone administered after MPTP on dopaminergic neurons of male mice.
000095 (2017)	Holly A. Fernandes [Canada] ; Norman W. Park [Canada] ; Quincy J. Almeida [Canada]	Effects of practice and delays on learning and retention of skilled tool use in Parkinson's disease.
000172 (2016)	Jenny Advocat ; Joanne Enticott ; Brooke Vandenberg ; Craig Hassed ; Jennifer Hester [Australie] ; Grant Russell	The effects of a mindfulness-based lifestyle program for adults with Parkinson’s disease: a mixed methods, wait list controlled randomised control study
000251 (2016)	Katherine Coulombe [Canada] ; Martine Saint-Pierre [Canada] ; Giulia Cisbani [Canada] ; Isabelle St-Amour [Canada] ; Claire Gibrat [Canada] ; Ariane Giguère-Rancourt [Canada] ; Frédéric Calon [Canada] ; Francesca Cicchetti [Canada]	Partial neurorescue effects of DHA following a 6-OHDA lesion of the mouse dopaminergic system.
000269 (2016)	Alencar Kolinski Machado [Brésil] ; Ana Cristina Andreazza [Canada] ; Tatiane Morgana Da Silva [Brésil] ; Aline Augusti Boligon [Brésil] ; Vanusa Do Nascimento [Brésil] ; Gustavo Scola [Canada] ; Angela Duong [Canada] ; Francine Carla Cadoná [Brésil] ; Euler Esteves Ribeiro [Brésil] ; Ivana Beatrice Mânica Da Cruz [Brésil]	Neuroprotective Effects of Açaí (Euterpe oleracea Mart.) against Rotenone In Vitro Exposure
000299 (2016)	Josée Savard [Canada] ; Hans Ivers [Canada] ; Marie-Hélène Savard [Canada] ; Charles M. Morin [Canada]	Long-Term Effects of Two Formats of Cognitive Behavioral Therapy for Insomnia Comorbid with Breast Cancer
000355 (2016)	Tiago A. Mestre [Canada] ; Anthony E. Lang [Canada] ; Michael S. Okun [États-Unis]	Factors influencing the outcome of deep brain stimulation: Placebo, nocebo, lessebo, and lesion effects.
000373 (2016)	Keith A. Wesnes [Royaume-Uni, Australie] ; Carl Gommoll [États-Unis] ; Changzheng Chen [États-Unis] ; Angelo Sambunaris [Géorgie (pays)] ; Roger S. Mcintyre [Canada] ; Philip D. Harvey [États-Unis]	Effects of levomilnacipran extended-release on major depressive disorder patients with cognitive impairments: post-hoc analysis of a phase III study
000503 (2015)	Christina Tremblay [Canada] ; Joël Macoir [Canada] ; Mélanie Langlois [Canada] ; Léo Cantin [Canada] ; Michel Prud'Homme [Canada] ; Laura Monetta [Canada]	The effects of subthalamic deep brain stimulation on metaphor comprehension and language abilities in Parkinson's disease.
000572 (2015)	Dongsun Park [Corée du Sud] ; Kyungha Shin [Corée du Sud] ; Ehn-Kyoung Choi [Corée du Sud] ; Youngjin Choi [Corée du Sud] ; Ja-Young Jang [Corée du Sud] ; Jihyun Kim [Corée du Sud] ; Heon-Sang Jeong [Corée du Sud] ; Wooryoung Lee [Corée du Sud] ; Yoon-Bok Lee [Corée du Sud] ; Seung Up Kim [Canada] ; Seong Soo Joo [Corée du Sud] ; Yun-Bae Kim [Corée du Sud, Canada]	Protective Effects of N-Acetyl-L-Cysteine in Human Oligodendrocyte Progenitor Cells and Restoration of Motor Function in Neonatal Rats with Hypoxic-Ischemic Encephalopathy
000579 (2015)	R T Bartus [États-Unis] ; J H Kordower [États-Unis] ; E M Johnson [États-Unis] ; L. Brown [États-Unis] ; B R Kruegel [États-Unis] ; Y. Chu [États-Unis] ; T L Baumann [États-Unis] ; A E Lang [Canada] ; C W Olanow [États-Unis] ; C D Herzog [États-Unis]	Post-mortem assessment of the short and long-term effects of the trophic factor neurturin in patients with α-synucleinopathies.
000619 (2015)	Hooman Ganjavi [Canada] ; Penny A. Macdonald	ON-OFF Effects of Dopaminergic Therapy on Psychiatric Symptoms in Parkinson's Disease.
000629 (2015)	Jinghua Liu ; Arjun H. Banskota ; Alan T. Critchley ; Jeff Hafting ; Balakrishnan Prithiviraj	Neuroprotective Effects of the Cultivated Chondrus crispus in a C. elegans Model of Parkinson’s Disease
000636 (2015)	Soojin Lee [Canada] ; Diana J. Kim [Canada] ; Daniel Svenkeson [États-Unis] ; Gabriel Parras [États-Unis] ; Meeko Mitsuko K. Oishi [États-Unis] ; Martin J. Mckeown [Canada]	Multifaceted effects of noisy galvanic vestibular stimulation on manual tracking behavior in Parkinson’s disease
000731 (2015)	Zaijun Zhang [République populaire de Chine] ; Guohui Li [République populaire de Chine] ; Samuel S W. Szeto [République populaire de Chine] ; Cheong Meng Chong [République populaire de Chine] ; Quan Quan [République populaire de Chine] ; Chen Huang [République populaire de Chine] ; Wei Cui [République populaire de Chine] ; Baojian Guo [République populaire de Chine] ; Yuqiang Wang [République populaire de Chine] ; Yifan Han [République populaire de Chine] ; K W Michael Siu [Canada] ; Simon Ming Yuen Lee [République populaire de Chine] ; Ivan K. Chu [République populaire de Chine]	Examining the neuroprotective effects of protocatechuic acid and chrysin on in vitro and in vivo models of Parkinson disease.
000744 (2015)	Sang Jin Kim ; Kaviraja Udupa ; Zhen Ni ; Elena Moro ; Carolyn Gunraj ; Filomena Mazzella ; Andres M. Lozano ; Mojgan Hodaie ; Anthony E. Lang ; Robert Chen	Effects of subthalamic nucleus stimulation on motor cortex plasticity in Parkinson disease
000745 (2015)	Filsy Samuel ; William P. Flavin ; Sobia Iqbal ; Consiglia Pacelli ; Sri Dushyaanthan Sri Renganathan ; Louis-Eric Trudeau ; Edward M. Campbell [États-Unis] ; Paul E. Fraser ; Anurag Tandon [Canada]	Effects of Serine 129 Phosphorylation on α-Synuclein Aggregation, Membrane Association, and Internalization*
000765 (2015)	Ziv Gan-Or ; Idan Amshalom ; Laura L. Kilarski ; Anat Bar-Shira ; Mali Gana-Weisz ; Anat Mirelman ; Karen Marder ; Susan Bressman ; Nir Giladi ; Avi Orr-Urtreger	Differential effects of severe vs mild GBA mutations on Parkinson disease
000798 (2015)	Mattia Volta [Canada] ; Stefano Cataldi [Canada] ; Dayne Beccano-Kelly [Canada] ; Lise Munsie [Canada] ; Igor Tatarnikov [Canada] ; Patrick Chou [Canada] ; Sabrina Bergeron [Canada] ; Emma Mitchell [Canada] ; Roscoe Lim [Canada] ; Jaskaran Khinda [Canada] ; Alejandro Lloret [États-Unis] ; C Frank Bennett [États-Unis] ; Carmela Paradiso [Italie] ; Michele Morari [Italie] ; Matthew J. Farrer [Canada] ; Austen J. Milnerwood [Canada]	Chronic and acute LRRK2 silencing has no long-term behavioral effects, whereas wild-type and mutant LRRK2 overexpression induce motor and cognitive deficits and altered regulation of dopamine release.

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Title.i -k "effects" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Title.i  \
                -Sk "effects" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Title.i
   |clé=    effects
}}

---

This area was generated with Dilib version V0.6.29. Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022